Sustainable circular development and manufacturing of healthcare products and their quantitative environmental impact assessment
This program, part of the Innovative Health Initiative (IHI) Joint Undertaking under Horizon Europe, focuses on fostering sustainable and circular practices in the healthcare product manufacturing sector. It aims to significantly reduce the environmental impact of medicines through innovative development and manufacturing processes. The call operates on a two-stage application procedure.
Who is Funded: Eligibility & Objectives
This section outlines the eligibility criteria for applicants, the geographical scope of the program, and its overarching objectives to promote sustainable and circular healthcare product development.
What is Funded: Project Scope & Focus
This section details the types of projects and thematic areas eligible for funding, focusing on reducing environmental impact in healthcare product manufacturing, along with relevant cost considerations and project maturity levels.
Type and Scope of Funding
Information regarding the type and financial scope of the funding, including the maximum available amount for selected projects. The program provides grants to drive innovation in sustainable healthcare manufacturing.
Conditions and Requirements
This section outlines critical conditions and requirements for applicants, covering aspects from application terms to specific legal provisions.
Application Procedure
This section provides a guide through the application process, from submission steps to how proposals are evaluated and selected for funding.
Legal Basis
This section identifies the fundamental legal and official documents that provide the authority and framework for the funding program.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
20,550,000 €
Allocated Budget:
20,550,000 €
Award Channel:
Framework Programme Call
Region:
European Union
Sectors:
Healthcare, Pharmaceutical Industry, Research and Development, Environmental and Climate Protection
Beneficiaries:
Healthcare, Pharmaceutical Industry
Application Type:
Consortium Required
Funding Stages:
Applied Research, Experimental Development, Product Development, Process Optimization, Implementation
Funding Provider
Program Level:
European Union
Funding Body:
Innovative Health Initiative Joint Undertaking (IHI JU), European Commission
Managed By:
Innovative Health Initiative Joint Undertaking (IHI JU)
Website: